21
5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10009 | JAK3-IN-7 | JAK | |
JAK3-IN-7 is a potent and selective JAK3 inhibitor (IC50<0.01 μM) for the treatment of rejection in organ transplantation, graft-versus-host reaction after organ transplantation, autoimmune disorders, allergic diseases, ... | |||
T26585 | AK301 | AK-301,AK 301 | Apoptosis , Microtubule Associated |
AK301 is a potent and selective inhibitor of tubulin polymerization and an effective sensitizer of cancer cells to apoptotic ligands (EC50 < 200 nM). Colon cancer cells arrested in mitosis with AK301 readily underwent a ... | |||
T27650 | JAK3i | JAK-3i,JAK 3i | JAK |
JAK3i is a selective covalent inhibitor of JAK3 kinase. JAK3i reveals two distinct temporal waves of STAT5 phosphorylation and more potently targets the second wave, which is required for cell cycle progression and T cel... | |||
T26174 | SAK3 | SAK 3,SAK-3 | Calcium Channel , AChR |
SAK3 is a novel modulator of nAChR activity that enhances T-type voltage-gated Ca2+ channel (T-VGCC) activity, and has potentiating effects on both Cav3.1 and Cav3.3 T-type Ca2+ channel currents.SAK3 is neuroprotective a... | |||
T67754 | JAK3-IN-14 | FLT | |
JAK3-IN-14 is a potent, selective and orally active FLT3 inhibitor, with IC50s of ∼40, 8, and 4 nM for FLT3-WT, FLT3-D835Y, and FLT3-D835H, respectively. | |||
T5492 | JAK3-IN-6 | JAK | |
JAK3-IN-6 is irreversible Janus Associated Kinase 3 (JAK3) inhibitor, with an IC50 of 0.15 nM | |||
T62553 | JAK3/BTK-IN-4 | ||
JAK3/BTK-IN-4 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets in autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signaling pathway has a synergistic effect and JAK3/BTK-IN-4 has pot... | |||
T61814 | JAK3-IN-9 | ||
JAK3-IN-9 is a potent and orally active inhibitor of the Janus kinase 3 (JAK3) enzyme, displaying an impressive IC50 value of 1.7 nM. It exhibits high selectivity towards the JAK3 signaling pathway, making it a valuable ... | |||
T62234 | JAK3/BTK-IN-3 | ||
JAK3/BTK-IN-3 is a potent inhibitor of JAK3/BTK. BTK and JAK3 are two important targets in autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway has a synergistic effect and JAK3/BTK-IN-3 has sh... | |||
T62114 | JAK3-IN-12 | ||
JAK3-IN-12 (compound 15k) is a potent inhibitor of JAK3 (IC50: 9.5 nM) and can be used in the study of rheumatoid arthritis. | |||
T15607 | JAK3-IN-1 | Others | |
JAK3-IN-1 is a selective and orally active JAK3 inhibitor (IC50: 4.8 nM). JAK3-IN-1 displays over 180-fold more selective for JAK3 than JAK1 (IC50: 896 nM) and JAK2 (IC50: 1050 nM). | |||
T62153 | JAK3/BTK-IN-5 | ||
JAK3/BTK-IN-5 is a potent inhibitor of JAK3/BTK. where BTK and JAK3 are two key targets in autoimmune diseases. Simultaneous inhibition of the BTK/JAK3 signalling pathway has a synergistic effect and JAK3/BTK-IN-5 has po... | |||
T63749 | JAK3-IN-13 | ||
JAK3-IN-13 is a potent, selective, orally active JAK3 inhibitor that acts on NK1 (IC50: 4728 nM), JNK2 (IC50: 2039 nM), JNK3 (IC50: 8 nM), and Tyk2 (IC50: 365 nM). JAK3-IN-13 exhibits anti-tumor effects. | |||
T11709 | JAK3 covalent inhibitor-1 | JAK | |
JAK3 Covalent Inhibitor-1 is a compound characterized by its potent and selective inhibition of Janus kinase 3 (JAK3), possessing an IC50 of 11 nM and demonstrating a 246-fold selectivity compared to other JAKs. | |||
T40334 | PROTAC IRAK3 degrade-1 | PROTAC IRAK3 degrade-1 | |
PROTAC IRAK3 degrade-1 is a potent and selective degrader of IRAK3 ( IC 50 = 5 nM). | |||
T9814 | JAK3/BTK-IN-1 | JAK , BTK | |
JAK3/ BTk-in-1 is a dual JAK3/BTK inhibitor that specifically targets and inhibits Janus kinase 3 (JAK3) and Bruton's tyrosine kinase (BTK), two important targets in autoimmune diseases. JAK3/ BTk-in-1 simultaneously inh... | |||
T9813 | JAK3/BTK-IN-2 | JAK , BTK | |
JAK3/ BTk-in-2 is a potent JAK3/BTK inhibitor. JAK3/ BTk-in-2 inhibits both BTK and JAK3, which are two important targets IN autoimmune diseases. JAK3/ BTk-in-2 simultaneously inhibits the BTK/JAK3 signaling pathway, sho... | |||
T77931 | PROTAC IRAK3 degrade-1 formic | PROTACs | |
PROTAC IRAK3 Degrade-1 (Compound 23) is a selective and potent IRAK3 degrader, demonstrating an IC50 value of 5 nM [1]. | |||
T62813 | JAK3/BTK-IN-6 | ||
JAK3/BTK-IN-6 is a potent dual inhibitor of BTK (IC50: 0.6 nM) and JAK3 (IC50: 0.4 nM).JAK3/BTK-IN-6 exhibits good metabolic stability in human liver microsomes.JAK3/BTK-IN-6 can be used to study blood and immune disease... | |||
T9811 | JAK3-IN-11 | ||
JAK3-IN-11 (Compound 12) exhibits potent, noncytotoxic, irreversible, orally active JAK3 inhibitory activity (IC50 = 1.7 nM) with an excellent selectivity profile (>588-fold compared to other JAK isoforms), covalently bi... | |||
T62556 | JAK-IN-23 | ||
JAK-IN-23 is an orally active dual JAK/STAT and NF-κB inhibitor that inhibits J AK1 (IC50: 8.9 nM), J AK2 (IC50: 15 nM), and J AK3 (IC50: 46.2 nM). JAK-IN-23 exhibits strong anti-inflammatory effects and can reduce the r... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01417 | AK3 Protein, Human, Recombinant (His & Myc) | Human | E. coli |
AK3 Protein, Human, Recombinant (His & Myc) is expressed in E. coli. | |||
TMPY-04469 | AK3L1 Protein, Human, Recombinant (His & GST) | Human | Baculovirus Insect Cells |
AK3L1 Protein, Human, Recombinant (His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 53 kDa and the accession number is P27144-1. | |||
TMPY-04755 | AK3L1 Protein, Human, Recombinant | Human | Baculovirus Insect Cells |
AK3L1 Protein, Human, Recombinant is expressed in Baculovirus insect cells. The predicted molecular weight is 25.3 kDa and the accession number is P27144-1. | |||
TMPH-02739 | IRAK3 Protein, Mouse, Recombinant (E. coli, His & Myc) | Mouse | E. coli |
IRAK3 Protein, Mouse, Recombinant (E. coli, His & Myc) is expressed in E. coli. | |||
TMPH-02738 | IRAK3 Protein, Mouse, Recombinant (His & Myc) | Mouse | Baculovirus Insect Cells |
Putative inactive protein kinase which regulates signaling downstream of immune receptors including IL1R and Toll-like receptors. Inhibits dissociation of IRAK1 and IRAK4 from the Toll-like receptor signaling complex by ... |